Model-based digital twins for biomarker development and virtual clinical trials in oncology

2025-2028

Digital twins in medicine are virtual representations of patients or organs that use data and predictive models to improve diagnosis, treatment and medical care. In this project, mathematical models will be developed and validated in three fields of recent interest in oncology: CAR T-cell immunotherapies for lymphomas, intermittent fasting strategies for cancer prevention and treatment, and radiopharmaceutical therapies. Digital twins will be used to discover biomarkers and deveop in-silico clinical trials. In this way we will generate hypotheses and proposals for alternative treatment strategies to improve patient survival and/or reduce treatment toxicity. 

Why Mathematics?

Mathematical methods are fundamental in the development and operation of digital twins, as they allow modeling, simulating and analyzing complex behaviors of biological systems.

The Team

Team members include Víctor M. Pérez-García (PI, full professor), Julián Pérez-Beteta, David Molina-García (Associate professors), Juan Jiménez-Sánchez (tenured assistant professor), Beatriz Ocaña Tienda (postdoc at CNIO), and PhD students Silvia Bordel, Yahir Calderón-Silva, Pablo Sanz and Andrés Méndiz.

Impact

The ultimate goal of the project is the use of digital twins for biomarker discovery and the development of in-silico clinical trials to generate hypotheses and proposals for alternative treatment strategies to improve patient survival and/or reduce treatment toxicity.

Funded by

The ultimate goal of the project is the use of digital twins for biomarker discovery and the development of in-silico clinical trials to generate hypotheses and proposals for alternative treatment strategies to improve patient survival and/or reduce treatment toxicity.